2023-05-23 09:53:45
The National Medicines Safety Agency (ANSM) wanted to sound the alarm on Monday regarding the growing difficulties in obtaining adrenaline auto-injectors. It is a pen-like device that allergy sufferers should always carry with them so that they can inject the substance in the event of a severe attack. The health authorities spoke of “supply tensions”.
Unavailability that increases demand
These concern in particular the Anapen, Epipen and Jext auto-injectors. The phenomenon is largely due to the discontinuation of the marketing of the Emerade pen model worldwide on May 4th. The situation has prompted consumers to turn to other brands. Emerade devices, sold in France since 2021, are no longer distributed in pharmacies in the country.
In question, “a risk of malfunction” having led to a “precautionary measure”, explained the ANSM in a press release while judging the danger “low”. To limit the impact of the strain, the agency recommended that doctors only prescribe other brands of pens once Emerade models reach their expiration date. She also recalled the importance for allergic subjects to always have two auto-injectors on them.
If Emerade pens have been temporarily withdrawn from sale, it is because their manufacturer, the Canadian Bausch, has detected a slightly abnormal number of devices no longer activating correctly if they have been dropped from one meter . However, no report of a problem linked to this risk has been recorded, assured the ANSM, which therefore did not consider it useful to “recall the Emerade auto-injectors already in the possession of patients”.
1684842414
#Adrenaline #autoinjectors #hardtoget #allergy #sufferers
